TipRanks
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
Hong Kong Market
2696
Shanghai Henlius Biotech, Inc. Class H
RESEARCH TOOLSreports
Want to see HK:2696 full AI Analyst Report?

Shanghai Henlius Biotech, Inc. Class H (2696) Ratios

8 Followers

Shanghai Henlius Biotech, Inc. Class H Ratios

HK:2696's free cash flow for Q2 2026 was ¥0.77. For the 2026 fiscal year, HK:2696's free cash flow was decreased by ¥ and operating cash flow was ¥0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.78 0.71 0.50 0.53 0.44
Quick Ratio
 0.65 0.58 0.35 0.38 0.29
Cash Ratio
 0.17 0.16 0.15 0.19 0.13
Solvency Ratio
 0.15 0.15 0.15 0.11 -0.06
Operating Cash Flow Ratio
 0.17 0.24 0.25 0.21 0.20
Short-Term Operating Cash Flow Coverage
 0.36 0.53 0.50 0.39 0.40
Net Current Asset Value
¥ -4.91B¥ -4.92B¥ -5.07B¥ -5.04B¥ -5.10B
Leverage Ratios
Debt-to-Assets Ratio
 0.30 0.29 0.34 0.41 0.41
Debt-to-Equity Ratio
 0.87 0.91 1.21 1.87 2.25
Debt-to-Capital Ratio
 0.47 0.48 0.55 0.65 0.69
Long-Term Debt-to-Capital Ratio
 0.25 0.24 0.24 0.34 0.37
Financial Leverage Ratio
 2.89 3.12 3.52 4.52 5.45
Debt Service Coverage Ratio
 0.54 0.55 0.43 0.31 -0.12
Interest Coverage Ratio
 0.00 8.18 7.64 5.71 -5.95
Debt to Market Cap
 0.17 0.12 0.28 0.53 0.56
Interest Debt Per Share
 7.25 6.77 6.94 7.70 6.98
Net Debt to EBITDA
 2.47 2.27 2.51 3.41 -9.67
Profitability Margins
Gross Profit Margin
74.69%74.77%73.10%72.64%73.73%
EBIT Margin
11.96%12.26%15.14%11.71%-18.30%
EBITDA Margin
17.06%18.70%20.02%16.89%-9.66%
Operating Profit Margin
12.06%12.26%16.41%11.71%-19.55%
Pretax Profit Margin
12.32%12.18%14.78%10.56%-21.58%
Net Profit Margin
11.67%12.08%14.33%10.12%-21.63%
Continuous Operations Profit Margin
11.67%12.08%14.33%10.12%-21.63%
Net Income Per EBT
94.71%99.25%97.00%95.86%100.20%
EBT Per EBIT
102.16%99.34%90.07%90.17%110.40%
Return on Assets (ROA)
6.62%6.51%7.74%5.51%-7.79%
Return on Equity (ROE)
20.41%20.33%27.23%24.91%-42.49%
Return on Capital Employed (ROCE)
10.67%11.01%16.87%13.06%-16.02%
Return on Invested Capital (ROIC)
7.96%8.45%11.21%7.93%-9.75%
Return on Tangible Assets
13.56%12.99%15.65%8.22%-15.14%
Earnings Yield
3.83%2.88%6.78%7.54%-11.35%
Efficiency Ratios
Receivables Turnover
 4.28 3.60 6.35 7.39 7.06
Payables Turnover
 2.46 2.02 2.11 2.71 1.18
Inventory Turnover
 3.07 2.75 2.11 1.95 1.12
Fixed Asset Turnover
 2.94 2.58 2.12 2.03 1.44
Asset Turnover
 0.57 0.54 0.54 0.54 0.36
Working Capital Turnover Ratio
 -7.05 -3.35 -2.33 -2.07 -1.56
Cash Conversion Cycle
 55.87 53.82 57.27 101.96 70.63
Days of Sales Outstanding
 85.24 101.28 57.47 49.41 51.72
Days of Inventory Outstanding
 118.72 132.96 172.63 187.27 327.27
Days of Payables Outstanding
 148.09 180.42 172.83 134.72 308.36
Operating Cycle
 203.96 234.24 230.10 236.68 378.99
Cash Flow Ratios
Operating Cash Flow Per Share
 1.49 2.13 2.29 1.92 1.81
Free Cash Flow Per Share
 1.17 1.58 0.74 0.07 -0.71
CapEx Per Share
 0.32 0.56 1.54 1.85 2.52
Free Cash Flow to Operating Cash Flow
 0.79 0.74 0.33 0.03 -0.39
Dividend Paid and CapEx Coverage Ratio
 4.67 3.83 1.48 1.04 0.72
Capital Expenditure Coverage Ratio
 4.67 3.83 1.48 1.04 0.72
Operating Cash Flow Coverage Ratio
 0.21 0.32 0.34 0.26 0.27
Operating Cash Flow to Sales Ratio
 0.11 0.17 0.22 0.19 0.31
Free Cash Flow Yield
2.83%3.07%3.35%0.50%-6.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 26.13 34.86 14.74 13.27 -8.81
Price-to-Sales (P/S) Ratio
 3.05 4.20 2.11 1.34 1.91
Price-to-Book (P/B) Ratio
 4.99 7.06 4.01 3.30 3.74
Price-to-Free Cash Flow (P/FCF) Ratio
 35.39 32.53 29.89 198.57 -15.97
Price-to-Operating Cash Flow Ratio
 27.79 24.05 9.74 6.91 6.24
Price-to-Earnings Growth (PEG) Ratio
 5.67 -13.16 0.30 -0.07 0.29
Enterprise Value Multiple
 20.33 24.71 13.06 11.36 -29.39
Enterprise Value
 25.78B 30.80B 14.97B 10.35B 9.13B
EV to EBITDA
 20.33 24.71 13.06 11.36 -29.39
EV to Sales
 3.47 4.62 2.62 1.92 2.84
EV to Free Cash Flow
 40.28 35.82 37.00 283.70 -23.80
EV to Operating Cash Flow
 31.65 26.48 12.06 9.88 9.30
Tangible Book Value Per Share
 -3.96 -4.03 -4.31 -1.96 -4.97
Shareholders’ Equity Per Share
 8.33 7.26 5.54 4.02 3.02
Tax and Other Ratios
Effective Tax Rate
 0.05 -0.02 0.03 0.04 >-0.01
Revenue Per Share
 13.65 12.21 10.53 9.88 5.93
Net Income Per Share
 1.59 1.48 1.51 1.00 -1.28
Tax Burden
 0.95 0.99 0.97 0.96 1.00
Interest Burden
 1.03 0.99 0.98 0.90 1.18
Research & Development to Revenue
 0.24 0.23 0.18 0.21 0.43
SG&A to Revenue
 0.39 0.40 0.40 0.07 0.11
Stock-Based Compensation to Revenue
 0.04 0.00 0.00 <0.01 <0.01
Income Quality
 0.94 1.44 1.51 1.84 -1.41
Currency in CNY